---
annotations:
- type: Pathway Ontology
  value: signaling pathway
authors:
- ReactomeTeam
- Egonw
description: The 22 members of the fibroblast growth factor (FGF) family of growth
  factors mediate their cellular responses by binding to and activating the different
  isoforms encoded by the four receptor tyrosine kinases (RTKs) designated FGFR1,
  FGFR2, FGFR3 and FGFR4. These receptors are key regulators of several developmental
  processes in which cell fate and differentiation to various tissue lineages are
  determined. Unlike other growth factors, FGFs act in concert with heparin or heparan
  sulfate proteoglycan (HSPG) to activate FGFRs and to induce the pleiotropic responses
  that lead to the variety of cellular responses induced by this large family of growth
  factors. An alternative, FGF-independent, source of FGFR activation originates from
  the interaction with cell adhesion molecules, typically in the context of interactions
  on neural cell membranes and is crucial for neuronal survival and development.<br><br>Upon
  ligand binding, receptor dimers are formed and their intrinsic tyrosine kinase is
  activated causing phosphorylation of multiple tyrosine residues on the receptors.
  These then serve as docking sites for the recruitment of SH2 (src homology-2) or
  PTB (phosphotyrosine binding) domains of adaptors, docking proteins or signaling
  enzymes. Signaling complexes are assembled and recruited to the active receptors
  resulting in a cascade of phosphorylation events.<br><br>This leads to stimulation
  of intracellular signaling pathways that control cell proliferation, cell differentiation,
  cell migration, cell survival and cell shape, depending on the cell type or stage
  of maturation.<br>  View original pathway at [http://www.reactome.org/PathwayBrowser/#DIAGRAM=5654741
  Reactome].
last-edited: 2021-01-25
organisms:
- Homo sapiens
redirect_from:
- /index.php/Pathway:WP3336
- /instance/WP3336
schema-jsonld:
- '@context': https://schema.org/
  '@id': https://wikipathways.github.io/pathways/WP3336.html
  '@type': Dataset
  creator:
    '@type': Organization
    name: WikiPathways
  description: The 22 members of the fibroblast growth factor (FGF) family of growth
    factors mediate their cellular responses by binding to and activating the different
    isoforms encoded by the four receptor tyrosine kinases (RTKs) designated FGFR1,
    FGFR2, FGFR3 and FGFR4. These receptors are key regulators of several developmental
    processes in which cell fate and differentiation to various tissue lineages are
    determined. Unlike other growth factors, FGFs act in concert with heparin or heparan
    sulfate proteoglycan (HSPG) to activate FGFRs and to induce the pleiotropic responses
    that lead to the variety of cellular responses induced by this large family of
    growth factors. An alternative, FGF-independent, source of FGFR activation originates
    from the interaction with cell adhesion molecules, typically in the context of
    interactions on neural cell membranes and is crucial for neuronal survival and
    development.<br><br>Upon ligand binding, receptor dimers are formed and their
    intrinsic tyrosine kinase is activated causing phosphorylation of multiple tyrosine
    residues on the receptors. These then serve as docking sites for the recruitment
    of SH2 (src homology-2) or PTB (phosphotyrosine binding) domains of adaptors,
    docking proteins or signaling enzymes. Signaling complexes are assembled and recruited
    to the active receptors resulting in a cascade of phosphorylation events.<br><br>This
    leads to stimulation of intracellular signaling pathways that control cell proliferation,
    cell differentiation, cell migration, cell survival and cell shape, depending
    on the cell type or stage of maturation.<br>  View original pathway at [http://www.reactome.org/PathwayBrowser/#DIAGRAM=5654741
    Reactome].
  keywords:
  - PI(4,5)P2
  - 'SOS1 '
  - translocation
  - 'p-4Y FGFR3(23-758)-TACC3(549-838) fusion '
  - 'FGFR3 Y373C '
  - 'p-6Y-FGFR3 795fs*139 '
  - FGFR3:p-4Y-PLCG1
  - 'S-Farn-Me KRAS4B '
  - 'UBC(229-304) '
  - FGFR3 (4;14)
  - p21 RAS:GTP
  - 'FRS2 '
  - 'SHC1-3 '
  - FGFR3 point mutants
  - FGFR3 cysteine
  - 'FGFR3 R248C '
  - 'FGFR3 point mutant dimers with enhanced kinase activity '
  - 'p-6Y-FGFR3 A391E '
  - 'S-Farn-Me PalmS NRAS '
  - 'p-6Y-FGFR3 G380R '
  - 'FGFR3b G697C '
  - cascade
  - 'p-Y55,Y227-SPRY2 '
  - FGFR3c P250R mutant
  - SRC-1
  - p-4Y-PLCG1
  - 'p-Y371-CBL '
  - PPA2A
  - FGFR3:PLCG1
  - 'p-S111,S120-SPRY2 '
  - 'FGF20 '
  - FGF23(25-251)
  - 'p-4Y FGFR3(23-793)-TACC3(143-838) fusion '
  - p-S111,S120-SPRY2
  - 'UBC(381-456) '
  - PP2A(A:C):S112/S121-pSPRY2
  - FGFR3 fusions
  - PTPN11
  - 'GTP '
  - FGFR3:p-FRS2:GRB2:GAB1:PIK3R1
  - 'GAB1 '
  - 'pY-FGFR3 '
  - 'FGFR3 G382D '
  - with enhanced
  - signaling
  - FGFR3b
  - 'PLCG1 '
  - FGFR3 fusion dimers
  - 'UBA52(1-76) '
  - FGFR3 mutant dimers
  - SPRY2:B-RAF
  - 'PIK3R1 '
  - 'FGF18 '
  - P250R mutant
  - 'FGFR3 G380R '
  - 'UBB(77-152) '
  - Activated FGFR3:SHC1
  - CBL
  - p-T,Y MAPK dimers
  - 'FRS3 '
  - Activated
  - 'PPP2CA '
  - 'RPS27A(1-76) '
  - DAG and IP3
  - 'FGFR3b '
  - Ub:Y55/Y227-pSPRY2:CBL
  - 'UBC(533-608) '
  - 'FGF1 '
  - PLCG1
  - 'p-6Y-FGFR3c '
  - FGFR3:p-FRS2:p-PTPN11:p-CBL:GRB2
  - 'p-6Y-FGFR3 S371C '
  - Y55/Y227-pSPRY2:CBL
  - 'p-6Y-FGFR3 K650Q '
  - 'p-S112,S115-SPRY2 '
  - 'FGF2(10-155) '
  - FGFR3:pY-SHC1:GRB2:SOS1
  - GRB2:GAB1:PIK3R1
  - 'PPP2CB '
  - FGFR3c-binding FGFs
  - 'p-6Y-FGFR3 G370C '
  - bound to FGF
  - 'p-Y239,Y240,Y317-SHC1-2 '
  - S111/S120
  - FGFR3:p-FRS2
  - 'UBC(457-532) '
  - FGFR3:p-FRS:GRB2:SOS1
  - 'p6Y-FGFR3c P250R '
  - 'p-4Y FGFR3(23-760)-BAIAP2L1(18-522) fusion '
  - dimers with
  - ADP
  - 'FGFR3 A391E '
  - p21 RAS:GDP
  - FRS3
  - 'FGF4 '
  - 'UBB(1-76) '
  - Activated FGFR3
  - 'FGFR3(23-760)-TACC3(612-838) fusion '
  - 'FGFR3(23-760)-TACC3(647-838) fusion '
  - 'PPP2R1A '
  - FGFR3:p-FRS:p-PTPN11
  - PPA2A (A:C):Y55/Y227
  - 'FGFR3 '
  - 'FGF16 '
  - t(4;14)
  - 'FGFR3 cysteine mutant dimers '
  - p-Y FGFR3 fusion
  - mutants with
  - mutants
  - FGFR3:p-FRS2:p-PTPN11
  - FGFR3c P250R
  - 'p-6Y-FGFR3 K650E '
  - FGFR3b homodimer
  - 'p-6Y-FGFR3 Y373C '
  - 'p-6Y-FGFR3 R248C '
  - 'p-4Y-PLCG1 '
  - inhibitors of FGFR3
  - 'FGFR3b S249C '
  - 'S-Farn-Me-PalmS KRAS4A '
  - 'p-6Y-FGFR3 G382D '
  - 'FGF17-1 '
  - 'FGFR3 G370C '
  - mutant dimers
  - 'UBC(609-684) '
  - cysteine mutants
  - HS
  - FRS2
  - 'PIK3CA '
  - PP2A (A:C)
  - 'p-T185,Y187-MAPK1 '
  - ATP
  - p-Y371-CBL:GRB2
  - 'p-6Y-FGFR3b G697C '
  - PP2A(A:C):Y55/Y227-pSPRY2
  - GalNAc-T178-FGF23(25-251)
  - PI(3,4,5)P3
  - 'UBC(153-228) '
  - dimers
  - p-SPRY2:B-RAF
  - 'FGF9 '
  - FGFR3c
  - 'p-6Y-FGFR3 K650M '
  - kinase activity
  - GTP
  - 'UBC(305-380) '
  - 'SHC1-2 '
  - GDP
  - 'AZD4547 '
  - 'FGFR3(23-758)-TACC3(549-838) fusion '
  - Pi
  - p-T250,T255,T385,S437-MKNK1
  - GRB2:GAB1
  - Activated FGFR3b
  - 'p-4Y FGFR3(23-760)-TACC3(612-838) fusion '
  - 'FGFR3 S371C '
  - FGFR3:p-FRS:PTPN11
  - FGFR3:p-FRS3
  - FGFR3:p-FRS2:GRB2:GAB1:PI3K
  - RAF/MAP kinase
  - 'SPRY2 '
  - (A:C):S112/S115
  - FGFR3:p-FRS
  - GRB2-1:SOS1
  - 'BRAF '
  - PIK3R1
  - complex:Ub-p-FRS2
  - 'PTPN11 '
  - 'UBB(153-228) '
  - 'FGFR3 K650E '
  - 'FGFR3c '
  - Activated FGFR3:FRS3
  - PPA2A(A:C):SPRY2
  - 'p-5Y-FRS3 '
  - dimers:TKIs
  - 'CBL '
  - FGFR3:p-8T-FRS2
  - activated
  - 'FGF8-1 '
  - 'p-4Y FGFR3(23-760)-TACC3(647-838) fusion '
  - GALNT3
  - SHC1-2,SHC1-3
  - 'FGFR3 K650Q '
  - 'p-Y546,Y584-PTPN11 '
  - FGFR3:p-FRS2:p-PTPN11:GRB2:GAB1:PI3K
  - 'p-T202,Y204-MAPK3 '
  - Activated FGFR3:FRS2
  - 'FGFR3c P250R '
  - BRAF
  - FGFR3b-binding FGFs
  - 'p-6Y-FGFR3 K650T '
  - FGFR3:pY-SHC1
  - 'FGFR3(23-758)-TACC3(649-838) fusion '
  - Activated FGFR3c
  - 'p-Y194,Y195,Y272-SHC1-3 '
  - 'FGFR3(23-760)-BAIAP2L1(18-522) fusion '
  - p-SPRY2:GRB2
  - 'FGFR3 (4;14) translocation mutant dimers '
  - Ub
  - activity
  - dimer bound to FGF
  - PP2A(A:C):SPRY2
  - p-SPRY2
  - 'UBC(1-76) '
  - GRB2-1
  - 'UBC(77-152) '
  - 'p-6Y-FGFR3b S249C mutant '
  - 'FGFR3 K650M '
  - Ub-Activated FGFR3
  - 'p-6Y-FGFR3 K650N '
  - enhanced kinase
  - Tyrosine kinase
  - FGFR3 mutant
  - UDP-GalNAc
  - FGFR3:p-FRS2:p-PTPN11:GRB2:GAB1:PIK3R1
  - 'p-6Y-FRS2 '
  - 'GalNAc-T178-FGF23(25-251) '
  - FGFR3c homodimer
  - 'S-Farn-Me-2xPalmS HRAS '
  - 'FGF5-1 '
  - 'HS '
  - 'FGFR3 K650T '
  - PIK3CA
  - UDP
  - 'p-6Y-FGFR3b '
  - 'p-8T-FRS2 '
  - Ub-(Y55/Y227)p-SPRY2
  - 'FGFR3 795fs*139 '
  - PIP3 activates AKT
  - 'p-S112,S121-SPRY2 '
  - FGFR3 point mutant
  - homodimer
  - 'GRB2-1 '
  - 'p-4Y FGFR3(23-758)-TACC3(649-838) fusion '
  - 'PI(3,4,5)P3 '
  - 'FGFR3(23-793)-TACC3(143-838) fusion '
  - 'GDP '
  - 'FGFR3 K650N '
  license: CC0
  name: Signaling by FGFR3
seo: CreativeWork
title: Signaling by FGFR3
wpid: WP3336
---